Australia markets closed

Krystal Biotech, Inc. (KRYS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
159.67+6.55 (+4.28%)
At close: 04:00PM EDT
159.00 -0.67 (-0.42%)
After hours: 04:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.55B
Enterprise value 4.03B
Trailing P/E 409.41
Forward P/E 416.67
PEG ratio (5-yr expected) N/A
Price/sales (ttm)87.40
Price/book (mrq)5.85
Enterprise value/revenue 79.47
Enterprise value/EBITDA 225.02

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 394.29%
S&P500 52-week change 323.57%
52-week high 3189.97
52-week low 382.09
50-day moving average 3165.68
200-day moving average 3128.95

Share statistics

Avg vol (3-month) 3388.65k
Avg vol (10-day) 3266.31k
Shares outstanding 528.51M
Implied shares outstanding 628.51M
Float 820.55M
% held by insiders 112.78%
% held by institutions 189.48%
Shares short (15 Apr 2024) 42.45M
Short ratio (15 Apr 2024) 47.84
Short % of float (15 Apr 2024) 411.35%
Short % of shares outstanding (15 Apr 2024) 48.59%
Shares short (prior month 15 Mar 2024) 42.24M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 21.56%
Operating margin (ttm)7.45%

Management effectiveness

Return on assets (ttm)-8.83%
Return on equity (ttm)1.68%

Income statement

Revenue (ttm)50.7M
Revenue per share (ttm)1.87
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -92.22M
Net income avi to common (ttm)10.93M
Diluted EPS (ttm)0.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)532.18M
Total cash per share (mrq)18.81
Total debt (mrq)8.09M
Total debt/equity (mrq)1.04%
Current ratio (mrq)17.76
Book value per share (mrq)27.58

Cash flow statement

Operating cash flow (ttm)-88.8M
Levered free cash flow (ttm)-74.41M